Sign in

CIK 0001806952

  • Non-accelerated filer
  • Smaller reporting company

Lyell Immunopharma, Inc.

Sign in to watch
Ticker
LYEL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
833006753
Phone
+1 650-695-0677
Business address
201 HASKINS WAY, SOUTH SAN FRANCISCO, CA, 94080
Open-market buys, last 90 days
$49,999,983
in 2 filings
Open-market sales, last 90 days
$215,781
in 9 filings

Net +$49,784,202. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 41 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-02-10 Hill Stephen J. Chief Operating Officer Grant or award · Option (right to buy) +450,000 450,000
2025-02-10 Hill Stephen J. Chief Operating Officer Grant or award · Option (right to buy) +56,250 56,250
2025-02-10 Newton Charles W. Chief Financial Officer Grant or award +112,500 172,725
2025-02-10 Newton Charles W. Chief Financial Officer Grant or award · Option (right to buy) +450,000 450,000
2025-02-10 Newton Charles W. Chief Financial Officer Grant or award · Option (right to buy) +56,250 56,250
2025-02-10 Lee Gary K. Chief Scientific Officer Grant or award +112,500 176,696
2025-02-10 Lee Gary K. Chief Scientific Officer Grant or award · Option (right to buy) +450,000 450,000
2025-02-10 Lee Gary K. Chief Scientific Officer Grant or award · Option (right to buy) +56,250 56,250
2024-10-31 Ramachandra Sumant Director Grant or award · Option (right to buy) +260,000 260,000
2024-06-14 NELSEN ROBERT Director Grant or award · Option (right to buy) +130,000 130,000
2024-06-14 Bishop Hans Edgar Director Grant or award · Option (right to buy) +130,000 130,000
2024-06-14 Klausner Richard Director Grant or award · Option (right to buy) +130,000 130,000
2024-06-14 RIEFLIN WILLIAM JL Director Grant or award · Option (right to buy) +130,000 130,000
2024-06-14 NABEL ELIZABETH G Director Grant or award · Option (right to buy) +130,000 130,000
2024-06-14 BRAWLEY OTIS W Director Grant or award · Option (right to buy) +130,000 130,000
2024-06-14 FRIEDMAN CATHY Director Grant or award · Option (right to buy) +130,000 130,000
2024-02-09 Lang Matthew Chief Business Officer Grant or award +50,000 50,000
2024-02-09 Lang Matthew Chief Business Officer Grant or award · Option (right to buy) +500,000 500,000
2024-02-09 Hill Stephen J. Chief Operating Officer Grant or award +40,000 48,928
2024-02-09 Hill Stephen J. Chief Operating Officer Grant or award · Stock Option (right to buy) +400,000 400,000

Page 6 of 8 · 156 trades